Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on ...

We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on Two Natural Cap’s Substack. In this article, we will ...

Last month, a baby got the world’s first personalized gene-editing treatment. What will this mean for millions of others with ...

We spoke with the developers and manufacturers of the CRISPR gene therapy used to treat KJ Muldoon’s rare genetic condition, ...

Baby KJ Muldoon, the first patient to successfully receive personalized CRISPR gene editing therapy has returned home after over 300 days at the hospital.

Amid a challenging gene editing climate, partnerships between researchers, regulators, and industry remain crucial for ...

Changing how biopharmas package their products, how regulators review new drugs and how mutated genes are fixed could make ...

KJ Muldoon, a 10-month-old baby, was diagnosed with the genetic disease carbamoyl-phosphate synthetase 1 deficiency after he ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how ...

Back in 1900 the life expectancy of people with Down Syndrome was 9 years. In 1984, it was 28 years, today it's leveled off ...